Rivka Ayalon, MD
Assistant Professor, Medicine
Biography
After receiving her medical degree, she completed a nephrology fellowship at Boston University Medical Center. Her research interests include rare kidney diseases.
Education
- Ben-Gurion University of the Negev, MD
- Ben-Gurion University of the Negev, BMedSc
Publications
- Published on 8/24/2024
Siskind SM, Yadav S, Solomon M, Knapp PE, Menn-Josephy H, Francis J, Rennke HG, Ayalon R, Modzelewski KL. Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer. AACE Clin Case Rep. 2024; 10(6):244-248. PMID: 39734505.
Read at: PubMed - Published on 12/6/2019
Safar-Boueri L, Piya A, Beck LH, Ayalon R. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatr Nephrol. 2021 01; 36(1):19-30. PMID: 31811540.
Read at: PubMed - Published on 3/11/2016
Gupta G, Fattah H, Ayalon R, Kidd J, Gehr T, Quintana LF, Kimball P, Sadruddin S, Massey HD, Kumar D, King AL, Beck LH. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation. Clin Transplant. 2016 Apr; 30(4):461-9. PMID: 26854647.
Read at: PubMed - Published on 12/29/2015
Al-Rabadi L, Ayalon R, Bonegio RG, Ballard JE, Fujii AM, Henderson JM, Salant DJ, Beck LH. Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report. Am J Kidney Dis. 2016 May; 67(5):775-8. PMID: 26744127.
Read at: PubMed - Published on 3/12/2015
Kattah A, Ayalon R, Beck LH, Sethi S, Sandor DG, Cosio FG, Gandhi MJ, Lorenz EC, Salant DJ, Fervenza FC. Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy. Am J Transplant. 2015 May; 15(5):1349-59. PMID: 25766759.
Read at: PubMed - Published on 7/1/2014
Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH, Schlumberger W, Salant DJ, van Paassen P, Tervaert JW. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol. 2014 Jul; 142(1):29-34. PMID: 24926082.
Read at: PubMed - Published on 4/8/2014
Hladunewich MA, Cattran D, Beck LH, Odutayo A, Sethi S, Ayalon R, Leung N, Reich H, Fervenza FC. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy. Nephrol Dial Transplant. 2014 Aug; 29(8):1570-7. PMID: 24714414.
Read at: PubMed - Published on 12/29/2013
Ayalon R, Beck LH. Membranous nephropathy: not just a disease for adults. Pediatr Nephrol. 2015 Jan; 30(1):31-9. PMID: 24375012.
Read at: PubMed - Published on 9/8/2013
Timmermans SA, Ayalon R, van Paassen P, Beck LH, van Rie H, Wirtz JJ, Verseput GH, Frenken LA, Salant DJ, Cohen Tervaert JW. Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy. Am J Kidney Dis. 2013 Dec; 62(6):1223-5. PMID: 24021909.
Read at: PubMed - Published on 8/13/2013
Wada Y, Saeki T, Yoshita K, Ayalon R, Kamimura K, Nakano M, Narita I. Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy. Clin Kidney J. 2013 Oct; 6(5):486-490. PMID: 24058729.
Read at: PubMed
View 5 more publications: View full profile at BUMC